A carregar...
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma
Adrenocortical carcinoma (ACC) is a rare, highly aggressive cancer, often insensitive to conventional chemotherapeutics agents. Early diagnosis, followed by radical surgical resection plus/minus adjuvant mitotane therapy, is nowadays the only valuable option. Unfortunately, one out of four patients...
Na minha lista:
| Publicado no: | J Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6463568/ https://ncbi.nlm.nih.gov/pubmed/31057613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/6072863 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|